Chemoinformaics analysis of 12,15-Octadecadiynoic acid, methyl ester
| Molecular Weight | 290.447 | nRot | 10 |
| Heavy Atom Molecular Weight | 260.207 | nRig | 3 |
| Exact Molecular Weight | 290.225 | nRing | 0 |
| Solubility: LogS | -5.672 | nHRing | 0 |
| Solubility: LogP | 5.488 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 51 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 21 | No. of Aromatic Carbocycles | 0 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 30 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 19 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
| nHA | 2 | APOL | 53.3378 |
| nHD | 0 | BPOL | 32.7002 |
| QED | 0.326 |
| Synth | 2.698 |
| Natural Product Likeliness | 0.789 |
| NR-PPAR-gamma | 0.513 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.995 |
| Pgp-sub | 0.001 |
| HIA | 0.032 |
| CACO-2 | -4.655 |
| MDCK | 0.00000964 |
| BBB | 0.642 |
| PPB | 0.957325 |
| VDSS | 0.954 |
| FU | 0.00222875 |
| CYP1A2-inh | 0.914 |
| CYP1A2-sub | 0.277 |
| CYP2c19-inh | 0.882 |
| CYP2c19-sub | 0.501 |
| CYP2c9-inh | 0.835 |
| CYP2c9-sub | 0.977 |
| CYP2d6-inh | 0.426 |
| CYP2d6-sub | 0.084 |
| CYP3a4-inh | 0.746 |
| CYP3a4-sub | 0.115 |
| CL | 9.311 |
| T12 | 0.514 |
| hERG | 0.004 |
| Ames | 0.011 |
| ROA | 0.062 |
| SkinSen | 0.973 |
| Carcinogencity | 0.665 |
| EI | 0.967 |
| Respiratory | 0.934 |
| NR-Aromatase | 0.099 |
| Antiviral | No |
| Prediction | 0.617683 |